Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Trends & Strategies Shaping the Global Smart Polymers Market, 2025-2035, by Type of Polymer, Stimulus, End User and Region Featuring Profiles of 22 Industry Players

The smart polymers market is expanding due to rising demand for adaptable, stimuli-responsive materials. Key opportunities include applications in biotechnology and medicine, integration with 3D ...
HotHardware

FEATURE REVIEWS

AMD FSR Redstone Tested: Four Big Radeon... Crucial X10 SSD Review: Fast, Rugged,... Best Black Friday Week Deals 2025: Top PC,... Alienware 16 & 18 Area-51 Laptops Reviewed:... AMD Zyphra GPU Cluster ...